NCKAP1 Inhibits the Progression of Renal Carcinoma via Modulating Immune Responses and the PI3K/AKT/mTOR Signaling Pathway
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26062813 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Xin Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory, Zhongshan Hospital (Xiamen), Fudan University, Xiamen 361015, China. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Kidney Neoplasms, Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Fujian Province.
Abstract (Originalsprache)
Nck-associated protein 1 (NCKAP1) is critical for cytoskeletal functions and various cellular activities, and deregulation of NCKAP1 in many cancers significantly influences the outcomes of malignant diseases. However, the functions of NCKAP1 in the progression of renal cancer are yet unknown. To investigate the specific roles of NCKAP1 in the immune regulation and tumor progression of renal cancer, the expression of NCKAP1 and genetic variations were analyzed across cancer types at different pathological stages via UALCAN and cBioPortal. Immune cell infiltration in renal cancer was also assessed by ssGSEA and single-cell gene expression data from the GEO. RNA sequencing of NCKAP1-overexpressing 769P cells further examined the impact of NCKAP1 on kidney cancer. Our pancancer analyses revealed a complex NCKAP1 expression profile across various cancer types, with reduced levels in renal cancer patients linked to patient prognosis. CIBERSORT and single-cell RNA sequencing revealed the expression patterns of NCKAP1 in different cell lineages in renal cancer and a significant correlation between NCKAP1 and immune cell infiltration in the kidney tumor microenvironment. We further verified that NCKAP1 suppressed cancer cell growth and affected tumor development in renal cancer via the PI3K/AKT/mTOR signaling pathway. Our results indicate that NCKAP1 is a potential predictive marker and treatment target for renal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Central Laboratory, Zhongshan Hospital (Xiamen), Fudan University, Xiamen 361015, China.
- Department of Urology, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, 1665 Kongjiang Road, Shanghai 200092, China.
- Shanghai Public Health Clinical Center, Fudan University, 2901 Caolang Road, Jinshan District, Shanghai 201508, China.
ORCID-Profile: Jin Wang
Förderung
- Natural Science Foundation of Fujian Province
Zitieren
APA
Zhang, X., Ye, J., Sun, L., Xu, W., He, X., Bao, J., & Wang, J. (2025). NCKAP1 Inhibits the Progression of Renal Carcinoma via Modulating Immune Responses and the PI3K/AKT/mTOR Signaling Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26062813
Vancouver
Zhang X, Ye J, Sun L, Xu W, He X, Bao J, et al. NCKAP1 Inhibits the Progression of Renal Carcinoma via Modulating Immune Responses and the PI3K/AKT/mTOR Signaling Pathway. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26062813
BibTeX
@article{Zhang2025,
author = {Zhang, Xin and Ye, Jianqing and Sun, Lixiang and Xu, Wanli and He, Xiaomeng and Bao, Juan and Wang, Jin},
title = {NCKAP1 Inhibits the Progression of Renal Carcinoma via Modulating Immune Responses and the PI3K/AKT/mTOR Signaling Pathway},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26062813}
}
EUVIMED